{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5079, "recent_count": 5, "transaction_limit": 160, "filters": {"q": "", "ticker": "ALKS", "sector": "", "industry": "", "side": "", "start": "2026-06-17", "end": "2026-08-01"}, "summary": {"total": 5, "acquisition_count": 1, "disposal_count": 4, "acquisition_value": 96700.0, "acquisition_value_label": "$96.7K", "disposal_value": 573517.79, "disposal_value_label": "$573.5K", "net_value": -476817.79, "net_value_label": "$-476.8K", "flow_tone": "negative", "largest_value_label": "$427.1K", "top_sector": "Healthcare", "window_label": "17 Jun 2026 to 01 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 5, "value": "670217.7900", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$670.2K"}], "days": [{"transaction_date": "2026-07-01", "acquisitions": 1, "disposals": 3, "total": 4, "bar_width": 100.0}, {"transaction_date": "2026-07-06", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 25.0}], "side_mix": {"acquisitions": 1, "disposals": 4, "acquisition_share": 20.0, "disposal_share": 80.0}}, "company_flows": [{"symbol": "ALKS", "name": "Alkermes Plc", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-specialty-generic/", "latest_transaction": "2026-07-06", "acquisitions": 1, "disposals": 4, "acquired_value": 96700.0, "acquired_value_label": "$96.7K", "disposed_value": 573517.79, "disposed_value_label": "$573.5K", "net_value": -476817.79, "net_value_label": "$-476.8K", "acquisition_share": 20.0, "disposal_share": 80.0, "detail_url": "https://sharemaestro.com/insider-activity/company/alks/", "research_links": {"chart": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/", "report": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/report/", "factor": "/factors/ticker/50d14756-dd0f-434b-9d95-0b5721cc6d60/"}}], "company_overview": [{"symbol": "ALKS", "name": "Alkermes Plc", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-specialty-generic/", "latest_transaction": "2026-07-06", "filings": 5, "acquisitions": 1, "disposals": 4, "acquired_value": 96700.0, "acquired_value_label": "$96.7K", "disposed_value": 573517.79, "disposed_value_label": "$573.5K", "net_value": -476817.79, "net_value_label": "$-476.8K", "acquisition_share": 20.0, "disposal_share": 80.0, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/alks/", "research_links": {"chart": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/", "report": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/report/", "factor": "/factors/ticker/50d14756-dd0f-434b-9d95-0b5721cc6d60/"}}], "transactions": [{"symbol": "ALKS", "name": "Alkermes Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-06", "executive": "GAFFIN, DAVID JOSEPH", "executive_title": "EVP, CLO, Alkermes, Inc.", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 2034.0, "share_price": 54.03, "transaction_value": 109897.02, "fetched_at": "2026-07-27T11:01:11.828158+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/alks/", "research_links": {"chart": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/", "report": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/report/", "factor": "/factors/ticker/50d14756-dd0f-434b-9d95-0b5721cc6d60/"}}, {"symbol": "ALKS", "name": "Alkermes Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "HOPKINSON, CRAIG C.", "executive_title": "EVP R&D, Chief Medical Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 8300.0, "share_price": 51.4613, "transaction_value": 427128.79, "fetched_at": "2026-07-21T22:05:56.218964+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/alks/", "research_links": {"chart": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/", "report": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/report/", "factor": "/factors/ticker/50d14756-dd0f-434b-9d95-0b5721cc6d60/"}}, {"symbol": "ALKS", "name": "Alkermes Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "HOPKINSON, CRAIG C.", "executive_title": "EVP R&D, Chief Medical Officer", "security_type": "Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 5000.0, "share_price": 19.34, "transaction_value": 96700.0, "fetched_at": "2026-07-21T22:05:56.217419+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/alks/", "research_links": {"chart": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/", "report": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/report/", "factor": "/factors/ticker/50d14756-dd0f-434b-9d95-0b5721cc6d60/"}}, {"symbol": "ALKS", "name": "Alkermes Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "HOPKINSON, CRAIG C.", "executive_title": "EVP R&D, Chief Medical Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 700.0, "share_price": 52.1314, "transaction_value": 36491.98, "fetched_at": "2026-07-21T22:05:56.220415+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/alks/", "research_links": {"chart": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/", "report": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/report/", "factor": "/factors/ticker/50d14756-dd0f-434b-9d95-0b5721cc6d60/"}}, {"symbol": "ALKS", "name": "Alkermes Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-07-01", "executive": "HOPKINSON, CRAIG C.", "executive_title": "EVP R&D, Chief Medical Officer", "security_type": "Employee Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 5000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-21T22:05:56.215902+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/alks/", "research_links": {"chart": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/", "report": "/terminal/50d14756-dd0f-434b-9d95-0b5721cc6d60/report/", "factor": "/factors/ticker/50d14756-dd0f-434b-9d95-0b5721cc6d60/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}